Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

@article{Reiter2002CellfreeHL,
  title={Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease},
  author={C. Reiter and Xunde Wang and J. Tanus-Santos and N. Hogg and R. Cannon and A. Schechter and M. Gladwin},
  journal={Nature Medicine},
  year={2002},
  volume={8},
  pages={1383-1389}
}
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide… Expand

Paper Mentions

Observational Clinical Trial
BIOCADRE is a CADRE substudy and aims to characterize more precisely the sickle cell patients with extreme phenotype.  
ConditionsSickle Cell Disease
InterventionBiological, Other
Interventional Clinical Trial
The prevalence of Sickle Cell Associated Nephropathy (SCAN) is increasing and is a growing concern. Microalbuminuria is detected in the early onset of SCAN. Noteworthy, as in diabetic… Expand
ConditionsSickle Cell Disease
InterventionDrug
Sickle cell anemia and vascular dysfunction: The nitric oxide connection
TLDR
The mechanisms of altered nitric oxide bioavailability in sickle cell anemia and its possible role in the pathogenesis of pulmonary hypertension are summarized. Expand
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy
TLDR
The combined effects of inhaled nitric oxide gas of improving pulmonary ventilation to perfusion matching and hemodynamics, reducing alveolar and systemic inflammation, and inhibiting circulating plasma hemoglobin may modulate the course of the disease, including the frequency and severity of vaso-occlusive crises and acute chest syndrome episodes. Expand
Erythrocytes and Vascular Function: Oxygen and Nitric Oxide
Erythrocytes regulate vascular function through the modulation of oxygen delivery and the scavenging and generation of nitric oxide (NO). First, hemoglobin inside the red blood cell binds oxygen inExpand
Arginine Metabolism and Nitric Oxide Bioavailability in Sickle Cell Disease
TLDR
The role of decreased levels of exhaled NO (FENO) in SCD patients with a history of the ACS and the effects of oral arginine therapy on the FENO levels are investigated and atopic asthma levels have been proposed as a noninvasive measure of inflammatory disease in the lung. Expand
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
The ability of oxyhemoglobin to inhibit nitric oxide (NO)-dependent activation of soluble guanylate cyclase and vasodilation provided some of the earliest experimental evidence that NO was theExpand
Nitric oxide and sickle cell disease—Is there a painful connection?
TLDR
Results support an alternative hypothesis: one proposing that altered nitric oxide signaling may contribute to the development of neuropathic and/or inflammatory pain in sickle cell disease through its role as a neurotransmitter. Expand
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
TLDR
NO bioavailability and NO responsiveness are greater in women than in men with sickle cell disease and determines adhesion molecule expression and endothelium-dependent blood flows are largely non-NO mediated in male patients. Expand
Potential therapeutic action of nitrite in sickle cell disease
TLDR
Nitrite is an effective anti-platelet and anti-adhesion agent that is activated by red blood cells, with enhanced potency under physiological hypoxia and in venous blood that may be useful therapeutically. Expand
Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis
TLDR
The understanding of the pathological effects of red cell hemolysis on endothelial function suggests that nitric oxide dysregulation may underlie the red cell storage lesion, driven by increased nitrics oxide catabolism and loss of nitricoxide-generating functionality. Expand
Endothelial Dysfunction Enhances Vasoconstriction Due to Scavenging of Nitric Oxide by a Hemoglobin-based Oxygen Carrier
TLDR
Reduction in low molecular weight hemoglobin concentrations to less than 1% is insufficient to abrogate the vasoconstrictor effects of HBOC infusion in healthy awake sheep or in mice with reduced vascular nitric oxide levels associated with endothelial dysfunction. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.
TLDR
The levels of nitrosylated hemoglobin are too low to affect overall hemoglobin oxygen affinity, but augmented NO transport to the microvasculature seems a promising strategy for improving microvascular perfusion. Expand
Nitric oxide reaction with red blood cells and hemoglobin under heterogeneous conditions
Understanding the interaction of nitric oxide (NO) with red blood cells (RBCs) is vital to elucidating the metabolic fate of NO in the vasculature. Because hemoglobin (Hb) is the most abundantExpand
Modulation of nitric oxide bioavailability by erythrocytes
TLDR
It is suggested that RBC membrane and cytoskeleton associated NO-inert proteins provide a barrier for NO diffusion and thus account for the reduction in the NO uptake rate of RBCs. Expand
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
TLDR
The results suggest that the rapid reactions of oxy- and deoxyhemoglobin with nitric oxide are the fundamental cause of the hypertension and Hemoglobins with decreased NO-scavenging activity may be more suitable for certain therapeutic applications than those that cause depletion of Nitric oxide. Expand
Intravascular flow decreases erythrocyte consumption of nitric oxide.
TLDR
It is shown that physiological concentrations of RBCs in the presence of intravascular flow does not inhibit NO-mediated vessel dilation, suggesting that R BCs under this condition are not an NO scavenger. Expand
Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition.
TLDR
Transfusion with cell-free, bovine crosslinked hemoglobin in cats can selective reductions in blood flow in the intestines, kidneys, and adrenal glands without evidence of renal dysfunction by a mechanism consistent with nitric oxide scavenging. Expand
Mechanism of NO-induced oxidation of myoglobin and hemoglobin.
TLDR
The results provide a protein engineering strategy for reducing hypertensive events caused by extracellular hemoglobin-based O2 carriers by examining the effects of Phe(B10) and Phe (E11) substitutions on the rates of NO-induced oxidation of the alpha and beta subunits in recombinant human hemoglobin. Expand
Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation.
TLDR
The results demonstrate that NO-heme reaction pathways predominate in vivo, NO binding to heme groups is a rapidly reversible process, and S-nitrosohemoglobin formation is probably not a primary transport mechanism for NO but may facilitate NO release from heme. Expand
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery.
TLDR
Results indicate that inhaled NO during blockade of regional NO synthesis can supply intravascular NO to maintain normal vascular function, and this effect may have application for the treatment of diseases characterized by endothelial dysfunction. Expand
Nitric oxide in the human respiratory cycle
Interactions of nitric oxide (NO) with hemoglobin (Hb) could regulate the uptake and delivery of oxygen (O2) by subserving the classical physiological responses of hypoxic vasodilation and hyperoxicExpand
...
1
2
3
4
5
...